Malignant tumor of breast (disorder)

Year Started: 2015

Whole and processed blood products



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months


Female

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 26 - 50%
Serum -60°C to -85°C N/A Not applicable 26 - 50%
Whole blood -60°C to -85°C N/A Not applicable 11 - 25%

Malignant neoplasm of liver (disorder)

Year Started: 2009

Snap frozen tumour and associated normal tissue



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months


Unknown

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) Liquid nitrogen liquid phase N/A Not applicable 100%

Malignant tumor of colon (disorder)

Year Started: 2015

Snap frozen tumour and associated normal tissue



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months


Unknown

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) Liquid nitrogen liquid phase N/A Non-affected 100%

Malignant tumor of kidney (disorder)

Year Started: 2009

tissue



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months


Unknown

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) Liquid nitrogen liquid phase N/A Not applicable 100%

Malignant tumor of lung (disorder)

Year Started: 2001

Processed blood products and tumour material



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months


Unknown

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma Under -85°C N/A Not applicable 26 - 50%
Serum -60°C to -85°C N/A Not applicable 26 - 50%
Tissue specimen Surgical procedure (procedure) Liquid nitrogen liquid phase N/A Not applicable 26 - 50%

Malignant lymphoma (disorder)

Year Started: 2001

Processed blood products



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months


Unknown

Adult (> 40 years)

3001 - 5000 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen liquid phase N/A Not applicable 100%

Malignant tumor of thyroid gland (disorder)

Year Started: 2009

Frozen cells



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Genomic datasets 0 - 3 months
Quality indicators 0 - 3 months


Unknown

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen liquid phase N/A Not applicable 100%

Malignant tumor of lung (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with primary tumour site in the lung and circulating cancer cells in the bloodstream



Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Unknown

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 11 - 25%
Serum -60°C to -85°C N/A Not applicable 26 - 50%

Malignant tumor of breast (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with primary tumour site in the breast and circulating cancer cells in the blood



Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Unknown

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 11 - 25%
Serum -60°C to -85°C N/A Not applicable 26 - 50%

Malignant neoplasm of skin (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with primary tumour site in the skin and circulating cancer cells in the bloodstream



Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Unknown

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 11 - 25%
Serum -60°C to -85°C N/A Not applicable 26 - 50%

Malignant tumor of colon (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with primary tumour site in the bowel and circulating cancer cells in the bloodstream



Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Unknown

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 11 - 25%
Serum -60°C to -85°C N/A Not applicable 26 - 50%

Malignant tumor of ovary (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with primary tumour site in the ovary and circulating cancer cells in the bloodstream



Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Unknown

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 11 - 25%
Serum -60°C to -85°C N/A Not applicable 26 - 50%

Malignant tumor of prostate (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with primary tumour site in the prostate and circulating cancer cells in the bloodstream



Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Unknown

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 11 - 25%
Serum -60°C to -85°C N/A Not applicable 26 - 50%

Osteosarcoma of bone (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with primary tumour site in the bone (sarcoma) and circulating cancer cells in the bloodstream



Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Unknown

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 11 - 25%
Serum -60°C to -85°C N/A Not applicable 26 - 50%

Malignant lymphoma (disorder)

Circulating Cancer Cells

Year Started: 2000

Blood products from patients with lymphoma as the primary tumour site and circulating cells in the bloodstream



Access:
Open in response to specific calls
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Unknown

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Not applicable 11 - 25%
Plasma -60°C to -85°C N/A Not applicable 11 - 25%
Serum -60°C to -85°C N/A Not applicable 26 - 50%

Malignant tumor of prostate (disorder)

ProCAID

Year Started: 2014

Serum, plasma and buffy coat isolated from whole blood at each treatment cycle. FFPE blocks also collected.



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months


Male

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) -60°C to -85°C N/A Not applicable 26 - 50%
Plasma -60°C to -85°C N/A Not applicable 26 - 50%
Serum -60°C to -85°C N/A Not applicable 26 - 50%
Tissue specimen Surgical procedure (procedure) RT Paraffin Not applicable 0 - 10%